Methylene blue improves the hepatopulmonary syndrome

Ann Intern Med. 2001 Sep 4;135(5):380-1. doi: 10.7326/0003-4819-135-5-200109040-00017.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Enzyme Inhibitors / therapeutic use*
  • Half-Life
  • Hepatopulmonary Syndrome / drug therapy*
  • Hepatopulmonary Syndrome / physiopathology
  • Humans
  • Methylene Blue / administration & dosage*
  • Methylene Blue / pharmacokinetics
  • Oxygen / blood

Substances

  • Enzyme Inhibitors
  • Oxygen
  • Methylene Blue